Register


Create a profile to access all of our events, including options to sign up for our in person meetings and to view the online content from our past conferences!


Video Platform

View all the content from the last 12 months

MD Newsletter

Stay up to date with everything MD Education

Tickets & Events

Save your space and register for our future events

Select what applies to you




Login

Gaining access to MD Education’s premium offerings is only a button away! Enter your email and password to get educated.

MD-Education logo
Register / Login
We're evolving!

The website is currently being upgraded to include our new suite of offerings. Check back at the end of the month for a breakdown of our new services!


Questions? Contact us at:


office@md-education.com

Want Cookies?


Currently, we're using cookies for tracking purposes. By tracking, we mean what pages of MD Education you visit, what forms you submit and how you interact with our site. We do not sell this data to anybody. Currently, the Cookies we use are needed to collect form data through HubSpot.


If you'd like to see what we do with your data, head over to our Privacy Policy


Presentations Coming Soon...

4th Annual

Thank you for registering to our ASH Satillite Symposium!

Please check your emails for registration confirmation.


CLL-Lymphoma

US Focus Meeting

Updating Knowledge & Clinical Practice in 2025


Marina del Rey Marriot, 4100 Admiralty Way, Marina Del Rey, CA 90292

May 2 - 3, 2025

Interested in supporting this meeting? Reach out to us here:

=

Co-chair

Susan O’Brien, MD

University of California, Irvine Medical Center, CA

=

Co-chair

Christopher Flowers, MD

MD Anderson Cancer Center, Houston, TX

Dear Colleagues and Friends,


We are delighted to extend our warmest invitation to the multinational congress CLL-Lymphoma US Focus 2025, to be held at Marina del Rey Marriot, 4100 Admiralty Way, Marina Del Rey, CA 90292 on May 2nd, 2025 to May 3rd, 2025.


This meeting provides pivotal collaboration aimed at advancing CLL-Lymphoma research and patient treatment.


This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts from around the world.


Engage in riveting presentations, participate in thought-provoking debates, round-table discussions, and connect with peers at informal social gatherings.



People stood in a circle, smiling, with a cup of water

Agenda & Faculty

CLL-Lymphoma US Focus Meeting, Friday, May 2, 2025 - Saturday, May 3, 2025

7:00 AM

Registration Opens

8:00 AM

Symposium Supported by AbbVie

9:00 AM

Coffee Break

Session I

9:15 AM

CLL Proteonomics and Immunoproteomics

=

Catherine Wu, MD

Dana-Farber Cancer Institute, Boston, MA

9:35 AM

How I Choose Which Frontline Treatment for Who

=

Nitin Jain, MD

MD Anderson Cancer Center, Houston, TX

9:55 AM

Dealing with Autoimmune Complications in CLL

=

Danielle Brander, MD

Duke University, Durham, NC

10:15 AM

Panel Discussion

10:35 AM

Coffee Break

Session II

10:55 AM

MRD in CLL, Ready for Use?

=

Carolyn Owen, MD

University of Calgary, Canada

11:15 AM

Richter Syndrome, What’s on the Horizon?

=

Mazyar Shadman, MD

Fred Hutchinson Cancer Center, Washington

11:35 AM

Debate: Doublets or Triplets in First-Line CLL

=

Doublets are Good Enough

Nicole Lamanna, MD

Herbert Irving Comprehensive Cancer Center, NY

=

Three is Better than Two

John Allan, MD

Weill Cornell Medicine, New York

12:15 PM

Panel Discussion

12:35 PM

Lunch Break + Faculty and Fellow Photo

1:25 PM

Symposium Supported by Lilly

Session III

2:10 PM

CAR-T in CLL

=

David Maloney, MD

Fred Hutchinson Cancer Center, Washington

2:30 PM

Non-covalent BTKi

=

Catherine Coombs, MD

UCI Health, California

2:50 PM

BTK Degraders

=

Alexey Danilov, MD

City of Hope Comprehensive Cancer Center, Duarte, CA

3:10 PM

Panel Discussion

3:30 PM

Symposium Supported by BMS

4:15 PM

Coffee Break

Session IV

4:35 PM

Debate: Continuous vs Fixed Duration Therapy in Frontline CLL

=

Fixed Duration

Matthew Davids, MD

Dana-Farber Cancer Institute, Boston, MA

=

Continuous Therapy is the Way to Go

Alessandra Ferrajoli, MD

MD Anderson Cancer Center, Houston, TX

5:15 PM

CNS Disease in CLL

=

Jennifer Brown, MD

Dana-Farber Cancer Institute, Boston, MA

5:35 PM

CLL Next Questions

=

Richard Furman, MD

Weill Cornell Medicine, New York

5:55 PM

Panel Discussion

6:15 PM

Adjourn